Last $23.85 USD
Change Today -0.65 / -2.65%
Volume 8.0K
FWP On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

forward pharma a/s-adr (FWP) Snapshot

Open
$24.34
Previous Close
$24.50
Day High
$24.34
Day Low
$23.47
52 Week High
01/26/15 - $27.44
52 Week Low
10/15/14 - $15.75
Market Cap
1.1B
Average Volume 10 Days
66.9K
EPS TTM
--
Shares Outstanding
45.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FORWARD PHARMA A/S-ADR (FWP)

forward pharma a/s-adr (FWP) Related Bloomberg News

View More Bloomberg News

forward pharma a/s-adr (FWP) Related Businessweek News

No Related Businessweek News Found

forward pharma a/s-adr (FWP) Details

Forward Pharma A/S, a biopharmaceutical company, focuses on the provision of dimethyl fumarate (DMF) formulations for the treatment of various immune disorders. It develops FP187, a DMF formulation to treat relapsing remitting multiple sclerosis and psoriasis. The company was founded in 2005 and is headquartered in Copenhagen, Denmark.

1 Employees
Last Reported Date: 10/15/14
Founded in 2005

forward pharma a/s-adr (FWP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

forward pharma a/s-adr (FWP) Key Developments

Forward Pharma A/S Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Forward Pharma A/S reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported operating loss was $4,333,000 compared to $3,574,000 for the same period last year. Net loss before tax was $8,605,000 compared to $3,533,000 for the same period last year. Net loss for the period Attributable to Equity holders of the parent was $8,550,000 or $0.27 per basic and diluted share compared to $3,506,000 or $0.12 per basic and diluted share for the same period last year. For the nine months, the company reported operating loss was $11,772,000 compared to $6,941,000 for the same period last year. Net loss before tax was $17,157,000 compared to $4,828,000 for the same period last year. Net loss for the period Attributable to Equity holders of the parent was $17,045,000 or $0.54 per basic and diluted share compared to $4,714,000 or $0.22 per diluted share for the same period last year. Net cash flows used in operating activities was $8,139,000 compared to $4,825,000 for the same period last year. Purchase of tangible assets was $5,000 compared to $1,000 for the same period last year.

Forward Pharma A/S Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 03:40 PM

Forward Pharma A/S Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 03:40 PM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom. Speakers: Joel D. Sendek, Chief Financial Officer.

Forward Pharma A/S Presents at Stifel Healthcare Conference 2014, Nov-18-2014 04:10 PM

Forward Pharma A/S Presents at Stifel Healthcare Conference 2014, Nov-18-2014 04:10 PM. Venue: The Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Joel D. Sendek, Chief Financial Officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FWP:US $23.85 USD -0.65

FWP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FWP.
View Industry Companies
 

Industry Analysis

FWP

Industry Average

Valuation FWP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FORWARD PHARMA A/S-ADR, please visit www.forward-pharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.